Activity
-
ExCellThera announces Zemcelpro® (UM171 Cell Therapy) receives conditional authorization from the European Commission as the first and only cell…
ExCellThera announces Zemcelpro® (UM171 Cell Therapy) receives conditional authorization from the European Commission as the first and only cell…
Liked by Michael Israels
-
It was a pleasure to meet Grace Lee Reynolds, the new CEO of MaRs Discovery District. Since 2010, MaRS-supported ventures have raised $19 billion in…
It was a pleasure to meet Grace Lee Reynolds, the new CEO of MaRs Discovery District. Since 2010, MaRS-supported ventures have raised $19 billion in…
Liked by Michael Israels
-
We are excited to welcome Timothy Key to the team as Head of Business Development! Joining us with deep experience in cell therapy, Tim will lead…
We are excited to welcome Timothy Key to the team as Head of Business Development! Joining us with deep experience in cell therapy, Tim will lead…
Liked by Michael Israels
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
More activity by Michael
-
🚀 𝐁𝐢𝐠 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞! CCRM Nordic’s first venture investment is official! We’re now a shareholder in Precision BioAnalytics, combining…
🚀 𝐁𝐢𝐠 𝐦𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞! CCRM Nordic’s first venture investment is official! We’re now a shareholder in Precision BioAnalytics, combining…
Liked by Michael Israels
-
🎉 Today we celebrated a major milestone at GoCo Health Innovation City: the 𝘁𝗮𝗸𝗹𝗮𝗴𝘀𝗳𝗲𝘀𝘁 (topping-out ceremony) for the new GoCo Active…
🎉 Today we celebrated a major milestone at GoCo Health Innovation City: the 𝘁𝗮𝗸𝗹𝗮𝗴𝘀𝗳𝗲𝘀𝘁 (topping-out ceremony) for the new GoCo Active…
Liked by Michael Israels
-
I’m excited to share that I’ve joined Conscience Medicines Network as Associate Director, Strategy & Business Development. Conscience is leveraging…
I’m excited to share that I’ve joined Conscience Medicines Network as Associate Director, Strategy & Business Development. Conscience is leveraging…
Liked by Michael Israels
-
𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: 𝗪𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝗢𝘂𝗿 𝗡𝗲𝘄 𝗕𝗼𝗮𝗿𝗱…
𝗗𝗿𝗶𝘃𝗶𝗻𝗴 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻: 𝗪𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝗢𝘂𝗿 𝗡𝗲𝘄 𝗕𝗼𝗮𝗿𝗱…
Liked by Michael Israels
-
7 years ago today, I received Kite Pharma Yescarta CAR-T Therapy in a phase 2 clinical trial at UCLA Health Ronald Reagan Westwood Hospital. I…
7 years ago today, I received Kite Pharma Yescarta CAR-T Therapy in a phase 2 clinical trial at UCLA Health Ronald Reagan Westwood Hospital. I…
Liked by Michael Israels
-
CCRM Australia had a productive and impactful year enabling translation, commercialization, and sustainable growth in Australia’s regenerative…
CCRM Australia had a productive and impactful year enabling translation, commercialization, and sustainable growth in Australia’s regenerative…
Liked by Michael Israels
-
Big news for development of in vivo CAR T cells: AbbVie (ABBV) to Acquire Capstan Therapeutics for $2.1 Billion #TCell #tcellrx #immunotherapy
Big news for development of in vivo CAR T cells: AbbVie (ABBV) to Acquire Capstan Therapeutics for $2.1 Billion #TCell #tcellrx #immunotherapy
Liked by Michael Israels
-
Here it is - our rhythm-driven sonic experience that we made in-house and debuted at #BIO2025 to unveil The Intelligent Factory: our vision of the…
Here it is - our rhythm-driven sonic experience that we made in-house and debuted at #BIO2025 to unveil The Intelligent Factory: our vision of the…
Liked by Michael Israels
-
Exciting developments in utilizing cancer-targeting CAR-T therapy for autoimmune conditions like lupus are gaining momentum. At OmniaBio, we are…
Exciting developments in utilizing cancer-targeting CAR-T therapy for autoimmune conditions like lupus are gaining momentum. At OmniaBio, we are…
Liked by Michael Israels
-
Proud to share a major milestone in translational medicine and Canadian biotech innovation. The European Medicines Agency (EMA) has just issued a…
Proud to share a major milestone in translational medicine and Canadian biotech innovation. The European Medicines Agency (EMA) has just issued a…
Liked by Michael Israels
-
Drop by our BIO booth to chat about our #artificialintelligence use in autologous CAR-T manufacturing.
Drop by our BIO booth to chat about our #artificialintelligence use in autologous CAR-T manufacturing.
Liked by Michael Israels
-
As we acknowledge CCRM’s 14th anniversary this month, we’re proud to celebrate and recognize our employees’ hard work, contributions and leadership…
As we acknowledge CCRM’s 14th anniversary this month, we’re proud to celebrate and recognize our employees’ hard work, contributions and leadership…
Liked by Michael Israels
-
I’m pleased to share that the Ontario Centre of Innovation (OCI) is partnering with CCRM to strengthen Ontario’s cell and gene therapy ecosystem and…
I’m pleased to share that the Ontario Centre of Innovation (OCI) is partnering with CCRM to strengthen Ontario’s cell and gene therapy ecosystem and…
Liked by Michael Israels
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More